VNDA
Vanda Pharmaceuticals Inc
NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY
$7.10
+0.71% today
Updated 2026-04-30
Market cap
$411.32M
P/E ratio
—
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
—
52W range
$4 – $10
Volume
2.8M
Vanda Pharmaceuticals Inc (VNDA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-20.1%
Last 4 quarters
Revenue YoY growth
+7.6%
Most recent quarter
EPS YoY growth
-2162.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-17.5%
2026-02-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-11 | $-1.81 | -84.7% | $7.42 | $6.12 | -17.5% |
| 2025-11-05 | $-0.38 | +15.6% | $4.35 | $4.41 | +1.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.98 | $-1.81 | -84.7% | $57.22M | +7.6% |
| 2025-09-30 | $-0.45 | $-0.38 | +15.6% | $56.26M | +18.1% |
| 2025-06-30 | $-0.36 | $-0.46 | -27.8% | $52.59M | +4.2% |
| 2025-03-31 | $-0.60 | $-0.50 | +16.7% | $50.04M | +5.4% |
| 2024-12-31 | $-0.11 | $-0.08 | +27.3% | $53.19M | +17.5% |
| 2024-09-30 | $-0.16 | $-0.09 | +43.8% | $47.65M | +22.8% |
| 2024-06-30 | $-0.21 | $-0.08 | +61.9% | $50.47M | +9.6% |
| 2024-03-31 | $0.05 | $-0.07 | -243.6% | $47.46M | -24.1% |
| 2023-12-31 | $-0.09 | $-0.04 | +55.6% | $45.27M | — |
| 2023-09-30 | $-0.04 | $0.00 | +106.0% | $38.81M | — |
| 2023-06-30 | $-0.13 | $0.03 | +123.1% | $46.06M | — |
| 2023-03-31 | $0.06 | $0.06 | +0.0% | $62.50M | — |
Frequently asked questions
Has Vanda Pharmaceuticals Inc beaten earnings estimates?
Vanda Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -20.1% over the last 4 quarters.
How does VNDA stock react to earnings?
VNDA stock has moved an average of -8.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Vanda Pharmaceuticals Inc's revenue growth rate?
Vanda Pharmaceuticals Inc reported year-over-year revenue growth of +7.6% in its most recent quarter, with EPS growing -2162.5% year-over-year.